Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

Global Fund secures deal to slash HIV treatment price

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.

HIV & AIDS

Study finds HIV stigma persists across US, South

While knowledge and treatment around HIV continues to improve, HIV stigma remains an issue surrounding the disease and the people who live with it, a forthcoming report finds.

HIV & AIDS

Exploring how uncertainty motivates actions in epidemics

In an epidemic, we often focus on three staple metrics: Who does or doesn't have the disease, the rate at which people are contracting the disease, and the mortality rates. What's often left out, as explored in a new book ...

Medical research

Researchers find new pathway for HIV invasion of cell nucleus

A study published on August 10, 2023, in the journal Nature Communications has identified a new pathway that human immune deficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and ...

HIV & AIDS

Pitt study points to new opportunities for HIV treatment

Sometimes in science, answers come serendipitously, where researchers aren't expecting to find them. That's what happened to Cristian Apetrei, Ivona Pandrea and their colleagues during a recent study on human immunodeficiency ...

Medical research

Study demonstrates ability to remove key barrier to an HIV cure

The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica ...

HIV & AIDS

The key to preventing HIV progression may lie in the gut

Restoring and improving gut health may be key to slowing HIV progression to AIDS, according to a new study by University of Pittsburgh infectious diseases scientists published today in the journal JCI Insight.

HIV & AIDS

Sydney's former HIV epicenter close to ending transmission

The inner-city area of Sydney, once the epicenter of Australia's HIV epidemic, is very close to becoming the first place in the world to reach the UN's target for ending transmission of the virus, researchers said on Monday.

HIV & AIDS

'Geneva patient' the latest in long-term remission from HIV

A man dubbed the "Geneva patient" is the latest person with HIV to be declared in long-term remission—however he did not receive a transplant with a virus-blocking gene mutation like previous cases, researchers said on ...